Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
Randomised placebo-controlled trial of the teduglutide in reducing parenteral nutrition and intravenous fluid requirements in patients with short bowel syndrome.